- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A new function for drug combination dose finding trials ; volume:14 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Scientific reports ; 14, Heft 1 (12.2.2024), 1-8, 12.2024
- Urheber
-
Xiao, Jiacheng
Zhang, Weijia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-53155-4
- URN
-
urn:nbn:de:101:1-2404220835296.520303886888
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xiao, Jiacheng
- Zhang, Weijia
- SpringerLink (Online service)
Ähnliche Objekte (12)
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
Biases affecting injected doses of an experimental drug during clinical trials
Biocombinatorial approaches for drug finding
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
Biases affecting injected doses of an experimental drug during clinical trials
Biocombinatorial approaches for drug finding
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
A multiple comparison procedure for dose‐finding trials with subpopulations
Too bad! Fixed dose combination antiretroviral drugs
Dose-finding studies in drug development for rare genetic diseases
Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
Biases affecting injected doses of an experimental drug during clinical trials